Primary outcome variables included placental growth rate, birth weight, and placental volume at term.
Examples of indicators of infant health at the population level include neonatal mortality rate, post neonatal mortality rate, infant mortality rate, birth weight distribution, and gestational age distribution [2],[3].
Limited evidence exists that Relative to the impact of BPA on birth rate, birth weight, and length of gestation, human data on birth weight are inconsistent; although animal studies suggest such an association, there are limited human studies on gestational length and preterm birth.
Both in HD patients and in peritoneal dialysis patients the increase of dialysis dose higher number of HD sessions and >24 28 h of HD per week, low-volume/highly frequent dwells, BUN levels <16 mmol/L has been associated with higher gestational age, live birth rates, birth weight and lower rates of maternal hypertension, polyhydramnios and prematurity.
Additional adverse sheep production impacts from SRLV include reduced birth rates, birth weights and lamb growth as well as import restrictions (Keen et al. 1997; Arsenault et al. 2003; Reina et al. 2009).
Conclusion: Previous obstetric outcome and weight gain by 24 weeks of gestation were associated significantly with fetal growth rate and birth weight; fetal growth rate, in turn, was associated significantly with length of gestation.
As outcomes of interest for prenatal care, we identified maternal smoking rate, caesarean-section (c-section) rate, infant mortality rate, and low birth weight rate.
Based on standard definitions, data on c-section rate, infant mortality rate, and low birth weight rate have good comparability.
For example, prenatal exposure of rats to 25 100 μg/m of the representative PAH, benzo[ a]pyrene (BaP), through maternal inhalation significantly decreased the fetal survival rate and birth weight in a dose-dependent manner (Archibong et al. 2002).
Targeted models of antenatal care have been developed to address these barriers, with evaluations showing improvements in clinic attendance, screening and treatment (e.g. sexually transmitted and urinary infections) uptake, immunisation rates, mean birth weight, and reduced rates of preterm birth [ 18- 21].
The c-section rate for Cuba was obtained from the World Health Organization, [ 20] and data for all countries on infant mortality rate and low birth weight rate (<2500 g) were obtained from the OECD and World Bank [ 11, 12].
